38 Paul Tudor Jones II Charles River Laboratories International Trades
Paul Tudor Jones II's position in Charles River Laboratories International is currently worth $714k. That's 0.01% of their equity portfolio (1191st largest holding). The first Charles River Laboratories International trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares 31 more times and sold shares on 22 occasions. The investor's estimated purchase price is $759k, resulting in a loss of 5.9%.
Avg closing price
Price range
Increased shares by 145.6% (+101k shares)
Q2 2025
Avg closing price
$133.19
Price range
$99.75
-
$151.89
Increased shares by 22.8% (+12.8k shares)
Q1 2025
Avg closing price
$167.66
Price range
$150.52
-
$190.14
New holding (+56.3k shares)
Q4 2024
Avg closing price
$192.62
Price range
$178.58
-
$220.69
Sold -19k shares
Q3 2024
Avg closing price
$207.57
Price range
$187.96
-
$245.29
Sold 8.2% shares (-1.7k shares)
Q2 2024
Avg closing price
$226.59
Price range
$206.39
-
$268.73
Sold 68.6% shares (-45.2k shares)
Q1 2024
Avg closing price
$238.81
Price range
$203.52
-
$273.43
Increased shares by 15.3% (+8.74k shares)
Q4 2023
Avg closing price
$196.66
Price range
$164.52
-
$238.84
New holding (+57.2k shares)
Q3 2023
Avg closing price
$205.30
Price range
$194.44
-
$217.61
Sold -16.2k shares
Q3 2022
Avg closing price
$215.88
Price range
$182.44
-
$250.54
Increased shares by 29.9% (+3.73k shares)
Q2 2022
Avg closing price
$244.35
Price range
$204.13
-
$302.40
Increased shares by 9.4% (+1.08k shares)
Q1 2022
Avg closing price
$308.36
Price range
$255.51
-
$362.11
New holding (+11.4k shares)
Q4 2021
Avg closing price
$388.52
Price range
$351.38
-
$448.68
Sold -3.37k shares
Q3 2021
Avg closing price
$415.31
Price range
$372.64
-
$458.30
Sold 75.6% shares (-10.4k shares)
Q2 2021
Avg closing price
$333.92
Price range
$294.17
-
$371.65
Increased shares by 55.7% (+4.93k shares)
Q1 2021
Avg closing price
$277.97
Price range
$249.67
-
$299.48
New holding (+8.85k shares)
Q4 2020
Avg closing price
$238.16
Price range
$222.00
-
$252.62
Sold -3.57k shares
Q2 2020
Avg closing price
$159.60
Price range
$118.84
-
$189.72
Increased shares by 41.4% (+1.05k shares)
Q1 2020
Avg closing price
$149.98
Price range
$98.90
-
$178.34
Sold 51.3% shares (-2.66k shares)
Q4 2019
Avg closing price
$138.46
Price range
$126.05
-
$152.76
New holding (+5.19k shares)
Q3 2019
Avg closing price
$134.08
Price range
$125.07
-
$143.67
News about Charles River Laboratories International Inc. and Paul Tudor Jones II
Contrasting CM Life Sciences II (NASDAQ:CMII) and Charles River Laboratories International (NYSE:CRL)
CM Life Sciences II (NASDAQ:CMII) and Charles River Laboratories International (NYSE:CRL) are both unclassified companies, but which is the better investment...